Healthcare | Mergers & Acquisitions

Immucor Acquires Division of Biopool

  • Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
  • Immucor retained TM Capital as financial advisor to assist in an acquisition program which would build the company’s position in the transfusion diagnostics marketplace
  • TM Capital assisted Immucor in negotiating the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)

See Press Release

Client Testimonial